MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx™ in recurrent pericarditis is fully funded through to a planned New Drug Application submission with the FDA.New data from the ARCHER ...
PSD Citywide, an international leader in enterprise asset management software solutions, today announced it has received a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback